TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1)

[Edit]

FLN29

TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1)
The innate immune system confers host defense against viral and microbial infection, and TRAFD1 is a negative feedback regulator that controls excessive immune responses.The deduced human and mouse proteins contain 582 and 576 amino acids, respectively. TRAFD1 has an N-terminal RING finger domain, followed by a zinc finger domain, and TRAF-N and TRAF-C domains. Northern blot analysis of mouse tissues showed expression skeletal muscle, brain, kidney, spleen, and bone marrow.FLN29 is activated by STAT1 and functions as a negative feedback regulator of TLR signaling downstream of TRAF6.Small interfering RNA-induced downregulation of Fln29 reversed these effects and increased the production of nitrous oxide. Fln29 inhibited Toll-like receptor (TLR) signaling by interacting directly with Traf6.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for TRAF Type Zinc Finger Domain Containing Protein 1 (TRAFD1) ELISA Kit Customized Service Offer
  1. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  2. "The finished DNA sequence of human chromosome 12." Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling."J. Biol. Chem. 280:41289-41297(2005) [PubMed] [Europe PMC] [Abstract]
  5. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  6. "A probability-based approach for high-throughput protein phosphorylation analysis and site localization."Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract]
  7. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
  8. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  9. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
  10. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  11. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  12. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  13. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  14. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  15. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  16. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  17. "Solution structure of the ZF-TRAF domain of FLN29 gene product."Submitted (JUN-2006) to the PDB data bank